Community Health Systems, Inc. (NYSE: CYH) announced that it has completed the divestiture of the 180‑bed Crestwood Medical Center in Huntsville, Alabama, along with its associated outpatient centers and practices, to Huntsville Hospital Health System for $459 million before transaction expenses. The sale included $9 million in transaction costs, resulting in a pre‑tax gain of $185 million and an after‑tax gain of $138 million for CYH.
The transaction is a key component of CYH’s portfolio optimization program, which has generated more than $1.7 billion in net proceeds since 2023. The sale reduces the company’s net leverage from 7.4× to 6.6× as of 2025 and brings the hospital count down to 64, allowing CYH to focus on its core network of high‑margin facilities.
The $459 million in cash proceeds will strengthen CYH’s balance sheet and free up liquidity for debt repayment and future investments. By removing a low‑margin, non‑core asset, the company is expected to improve its operating leverage and free cash flow, positioning it to address upcoming debt maturities in 2027 and 2029.
In February 2026, CEO Kevin Hammons said the company was “getting closer to the end of our programmatic divestitures” while remaining “opportunistic regarding further asset sales” that would “materially deleverage” the firm. CFO Jason Johnson noted that completed and pending divestitures were expected to reduce net revenue and EBITDA in 2026, underscoring the trade‑off between scale and financial flexibility.
The Crestwood sale is part of a broader trend of divestitures in 2026, as CYH continues to streamline its operations and concentrate on core markets. The transaction reflects the company’s strategic shift toward a leaner, more profitable portfolio while maintaining service continuity for the Huntsville community.
No immediate market reaction to the sale has been reported, and the transaction is not expected to alter the company’s short‑term earnings outlook beyond the recognized gain and balance‑sheet benefits.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.